Total Payments
$10,632
2024 Payments
$1,618
Companies
49
Transactions
476
Medicare Patients
10,514
Medicare Billing
$1.6M
Payment Breakdown by Category
Food & Beverage$8,941 (84.1%)
Travel$1,495 (14.1%)
Education$195.92 (1.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,941 | 464 | 84.1% |
| Travel and Lodging | $1,495 | 6 | 14.1% |
| Education | $195.92 | 6 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $1,110 | 10 | $0 (2018) |
| GlaxoSmithKline, LLC. | $812.97 | 56 | $0 (2024) |
| Veran Medical Technologies, Inc. | $811.55 | 4 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $675.19 | 23 | $0 (2024) |
| Philips Electronics North America Corporation | $667.87 | 32 | $0 (2023) |
| Actelion Pharmaceuticals US, Inc. | $653.21 | 26 | $0 (2024) |
| United Therapeutics Corporation | $637.87 | 22 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $626.33 | 26 | $0 (2024) |
| Mylan Specialty L.P. | $586.83 | 31 | $0 (2024) |
| Electromed, Inc. | $433.96 | 40 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,618 | 69 | AstraZeneca Pharmaceuticals LP ($381.39) |
| 2023 | $1,750 | 91 | Actelion Pharmaceuticals US, Inc. ($284.04) |
| 2022 | $1,352 | 80 | Actelion Pharmaceuticals US, Inc. ($197.27) |
| 2021 | $1,044 | 64 | GlaxoSmithKline, LLC. ($173.32) |
| 2020 | $358.88 | 19 | GlaxoSmithKline, LLC. ($52.44) |
| 2019 | $909.71 | 49 | Philips Electronics North America Corporation ($282.45) |
| 2018 | $1,592 | 47 | Veran Medical Technologies, Inc. ($811.55) |
| 2017 | $2,008 | 57 | BOSTON SCIENTIFIC CORPORATION ($993.87) |
All Payment Transactions
476 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: SURGERY | ||||||
| 12/13/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $27.95 | General |
| Category: Pulmonology | ||||||
| 12/13/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $16.66 | General |
| Category: HFCWO | ||||||
| 12/13/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Respiratory | ||||||
| 12/09/2024 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $27.33 | General |
| Category: PULMONOLOGY | ||||||
| 11/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $32.57 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $25.91 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/05/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: PULMONOLOGY | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Education | In-kind items and services | $23.32 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Education | In-kind items and services | $21.72 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Respiratory | ||||||
| 10/14/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $27.05 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 10/14/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $14.77 | General |
| Category: HFCWO | ||||||
| 10/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $34.90 | General |
| Category: RESPIRATORY | ||||||
| 10/04/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Pulmonology | ||||||
| 10/04/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $15.12 | General |
| Category: HFCWO | ||||||
| 10/01/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $31.11 | General |
| Category: NEUROLOGY | ||||||
| 09/04/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Respiratory | ||||||
| 08/23/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $17.17 | General |
| Category: HFCWO | ||||||
| 08/23/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Respiratory | ||||||
| 08/21/2024 | Philips North America LLC | (6299) DreamWear (Device) | Food and Beverage | Cash or cash equivalent | $23.02 | General |
| Category: Medical Device | ||||||
| 08/20/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 08/15/2024 | ZOLL Respicardia, Inc. | remede System (Device) | Food and Beverage | Cash or cash equivalent | $24.37 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 2,754 | 8,207 | $1.2M | $417,135 |
| 2022 | 33 | 2,742 | 8,311 | $1.2M | $383,239 |
| 2021 | 32 | 2,711 | 10,650 | $1.3M | $449,877 |
| 2020 | 23 | 2,307 | 4,130 | $998,139 | $368,079 |
Total Patients
10,514
Total Services
31,298
Medicare Billing
$1.6M
Procedure Codes
129
All Medicare Procedures & Services
129 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 213 | 441 | $216,090 | $72,502 | 33.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 372 | 735 | $183,750 | $67,261 | 36.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 324 | 746 | $126,820 | $45,408 | 35.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 251 | 420 | $92,400 | $34,903 | 37.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 216 | 226 | $103,056 | $30,012 | 29.1% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 20 | 1,902 | $66,570 | $21,064 | 31.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 124 | 160 | $48,000 | $19,687 | 41.0% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 36 | 37 | $41,995 | $17,656 | 42.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 100 | 100 | $36,000 | $14,835 | 41.2% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 60 | 342 | $46,854 | $12,484 | 26.6% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 25 | 26 | $28,106 | $11,765 | 41.9% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 54 | 286 | $40,040 | $10,510 | 26.2% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 25 | 166 | $26,660 | $9,279 | 34.8% |
| Q3014 | Telehealth originating site facility fee | Office | 2023 | 221 | 327 | $19,620 | $6,978 | 35.6% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 18 | 83 | $14,960 | $6,817 | 45.6% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 126 | 129 | $15,609 | $5,365 | 34.4% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 126 | 129 | $12,255 | $5,160 | 42.1% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 22 | 1,320 | $20,880 | $3,804 | 18.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 125 | 128 | $18,048 | $3,604 | 20.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 54 | 61 | $10,980 | $3,327 | 30.3% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2023 | 34 | 36 | $12,600 | $2,518 | 20.0% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 13 | 14 | $2,900 | $1,966 | 67.8% |
| 31622 | Diagnostic exam of lung airway using an endoscope | Facility | 2023 | 16 | 16 | $8,320 | $1,603 | 19.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 24 | 83 | $3,735 | $1,443 | 38.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $5,130 | $1,375 | 26.8% |
About Dr. Jugroop Brar, MD
Dr. Jugroop Brar, MD is a Critical Care Medicine healthcare provider based in Surprise, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2005. The National Provider Identifier (NPI) number assigned to this provider is 1548263825.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jugroop Brar, MD has received a total of $10,632 in payments from pharmaceutical and medical device companies, with $1,618 received in 2024. These payments were reported across 476 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($8,941).
As a Medicare-enrolled provider, Brar has provided services to 10,514 Medicare beneficiaries, totaling 31,298 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 129 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease, Sleep Medicine
- Location Surprise, AZ
- Active Since 05/31/2005
- Last Updated 03/17/2015
- Taxonomy Code 207RC0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1548263825
Products in Payments
- Spin (Device) $811.55
- OPSUMIT (Drug) $556.18
- GENERAL - BILIARY DEVICES (Device) $503.56
- NUCALA (Biological) $468.82
- OFEV (Drug) $466.62
- GENERAL - PULMONARY (Device) $460.93
- SMARTVEST (Device) $433.96
- ORENITRAM (Drug) $432.24
- DUPIXENT (Biological) $410.50
- AIRSUPRA (Drug) $396.85
- Yupelri (Drug) $348.67
- TEZSPIRE (Biological) $239.48
- XOLAIR (Biological) $236.39
- inCourage (Device) $234.43
- YUPELRI (Drug) $226.61
- Xolair (Biological) $222.08
- TRELEGY ELLIPTA (Drug) $217.36
- TYVASO (Drug) $205.63
- Wakix (Drug) $186.91
- (8874) inCourage (Device) $154.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Surprise
Ms. Francisca Olibarria, Fnp-C, FNP-C
Critical Care Medicine — Payments: $4,181
Critical Care Medicine $4,181
Dr. Ravali Nagothu, Md, MD
Critical Care Medicine — Payments: $1,272
Critical Care Medicine $1,272
Reed Whittington, Rn, RN
Critical Care Medicine — Payments: $121.84
Critical Care Medicine $121.84